Markus Guilherme Dieken

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany.

Ratiopharm International GmbH develops, manufactures and distributes generic medicines and biopharmaceuticals. It offers prescription and non-prescription preparations, including biotechnological products, tablets, creams, suppositories, ointment, ampoules, and liquids. The firm also produces medicines for the treatment of skin diseases, arthritis, asthma, bronchitis, diabetes, cardiovascular diseases, and cancer with tumor blockers and immune modifiers. The company was founded in 1973 and is headquartered in Ulm, Germany.

Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany.

Gematik Gesellschaft für Telematikanwendungen der is a private company based in Berlin, Germany. The CEOs of the German company are Alexander Beyer, Markus Guilherme Dieken. The company is responsible for the telematics infrastructure (TI), which is the central platform for digital applications in German healthcare.